Newsroom - Page 2

What We’re Reading, April 29, 2016: While sales of Gilead's Harvoni drop, NY state attorney's decision could be good news for the company; and the FDA faces a lawsuit from a consumer advocacy group.
Overall use of a web-based tool providing real-time, personalized episode-level price estimates for healthcare was low, but for some procedures the number of people searching for prices of services was high relative to the number of people who received the service.
A small study in 30 patients with advanced B-cell acute lymphoblastic leukemia has further strengthened the faith in the potential of chimeric antigen receptor or CAR-T cell therapy.
Unlike its closest rival, CVS Health, Express Scripts does not have a retail healthcare delivery infrastructure.
One leading expert called the proposal the most substantive change in decades, but some feared CMS is once again hastening the demise of the independent physician.
A company in Canada, Biolyse Pharma, has offered to manufacture a generic version of enzalutamide at a significantly lower price than what CMS paid in 2014.
What we're reading, April 28, 2016: Valeant officials express remorse over price hikes of heart drugs; Paul Ryan proposes placing consumers with serious medical conditions in high-risk pools; and a British medical organization is urging smokers to switch to e-cigarettes.
Patients whose hospital care providers used mobile secure text messaging to communicate had shorter hospital stays compared with patients whose health providers used standard paging systems to communicate.
Feature
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
HF Compendium
$AD300x250BB$
$vacMongoViewPlus$